|
|
spermatogenesis
|
GO:0007283 |
200 |
0.273
|
|
|
|
cellular catabolic process
|
GO:0044248 |
372 |
0.182
|
Human |
|
|
male gamete generation
|
GO:0048232 |
201 |
0.170
|
|
|
|
positive regulation of response to stimulus
|
GO:0048584 |
323 |
0.146
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
109 |
0.108
|
Human |
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
136 |
0.093
|
|
|
|
microtubule organizing center organization
|
GO:0031023 |
168 |
0.087
|
|
|
|
cell cell signaling involved in cell fate commitment
|
GO:0045168 |
210 |
0.074
|
|
|
|
brain development
|
GO:0007420 |
120 |
0.074
|
Human |
|
|
centrosome cycle
|
GO:0007098 |
137 |
0.067
|
|
|
|
sex differentiation
|
GO:0007548 |
81 |
0.066
|
|
|
|
cell motility
|
GO:0048870 |
251 |
0.065
|
|
|
|
organic substance catabolic process
|
GO:1901575 |
308 |
0.062
|
Human |
|
|
spermatid differentiation
|
GO:0048515 |
114 |
0.059
|
|
|
|
organonitrogen compound metabolic process
|
GO:1901564 |
318 |
0.057
|
Human |
|
|
oxoacid metabolic process
|
GO:0043436 |
103 |
0.054
|
|
|
|
organic acid metabolic process
|
GO:0006082 |
103 |
0.053
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
108 |
0.052
|
Human |
|
|
ribonucleoside catabolic process
|
GO:0042454 |
112 |
0.052
|
Human |
|
|
positive regulation of signaling
|
GO:0023056 |
243 |
0.052
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
23 |
0.047
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
165 |
0.046
|
Human |
|
|
positive regulation of signal transduction
|
GO:0009967 |
223 |
0.046
|
|
|
|
positive regulation of cell communication
|
GO:0010647 |
250 |
0.045
|
|
|
|
activation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0006919 |
16 |
0.042
|
|
|
|
intracellular transport
|
GO:0046907 |
228 |
0.041
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
163 |
0.040
|
|
|
|
reproductive structure development
|
GO:0048608 |
74 |
0.037
|
|
|
|
regionalization
|
GO:0003002 |
416 |
0.036
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
38 |
0.035
|
Human |
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
117 |
0.035
|
|
|
|
catabolic process
|
GO:0009056 |
409 |
0.034
|
Human |
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
118 |
0.034
|
Human |
|
|
larval development
|
GO:0002164 |
104 |
0.034
|
|
|
|
spermatid development
|
GO:0007286 |
98 |
0.033
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
36 |
0.032
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
108 |
0.032
|
Human |
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
108 |
0.032
|
Human |
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
39 |
0.032
|
Human |
|
|
peptidyl proline modification
|
GO:0018208 |
3 |
0.031
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
109 |
0.031
|
Human |
|
|
positive regulation of peptidase activity
|
GO:0010952 |
29 |
0.030
|
|
|
|
compound eye development
|
GO:0048749 |
307 |
0.030
|
|
|
|
nucleobase containing compound catabolic process
|
GO:0034655 |
165 |
0.028
|
Human |
|
|
regulation of multicellular organismal development
|
GO:2000026 |
414 |
0.028
|
|
|
|
atp catabolic process
|
GO:0006200 |
38 |
0.028
|
Human |
|
|
negative regulation of gene expression
|
GO:0010629 |
387 |
0.027
|
|
|
|
reproductive system development
|
GO:0061458 |
74 |
0.027
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
39 |
0.027
|
Human |
|
|
organophosphate catabolic process
|
GO:0046434 |
112 |
0.027
|
Human |
|
|
aromatic compound catabolic process
|
GO:0019439 |
166 |
0.025
|
Human |
|
|
positive regulation of proteolysis
|
GO:0045862 |
52 |
0.025
|
|
|
|
proteolysis
|
GO:0006508 |
192 |
0.025
|
|
|
|
purine ribonucleoside monophosphate biosynthetic process
|
GO:0009168 |
3 |
0.024
|
|
|
|
compound eye morphogenesis
|
GO:0001745 |
249 |
0.024
|
|
|
|
protein maturation
|
GO:0051604 |
71 |
0.024
|
|
|
|
body morphogenesis
|
GO:0010171 |
2 |
0.023
|
|
|
|
regulation of molecular function
|
GO:0065009 |
217 |
0.023
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
109 |
0.022
|
Human |
|
|
intracellular signal transduction
|
GO:0035556 |
300 |
0.022
|
|
|
|
multi organism behavior
|
GO:0051705 |
175 |
0.022
|
|
|
|
establishment of localization in cell
|
GO:0051649 |
402 |
0.022
|
|
|
|
negative regulation of cellular biosynthetic process
|
GO:0031327 |
277 |
0.022
|
|
|
|
negative regulation of signal transduction
|
GO:0009968 |
206 |
0.022
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
381 |
0.022
|
|
|
|
positive regulation of catalytic activity
|
GO:0043085 |
118 |
0.022
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
38 |
0.021
|
Human |
|
|
carboxylic acid metabolic process
|
GO:0019752 |
92 |
0.021
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
242 |
0.021
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
112 |
0.021
|
Human |
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
112 |
0.020
|
Human |
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
28 |
0.020
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
174 |
0.020
|
Human |
|
|
regulation of proteolysis
|
GO:0030162 |
87 |
0.019
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
61 |
0.019
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
110 |
0.019
|
Human |
|
|
small molecule metabolic process
|
GO:0044281 |
305 |
0.019
|
Human |
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
128 |
0.019
|
Human |
|
|
heterocycle catabolic process
|
GO:0046700 |
166 |
0.018
|
Human |
|
|
dorsal ventral pattern formation
|
GO:0009953 |
133 |
0.018
|
|
|
|
regulation of compound eye retinal cell programmed cell death
|
GO:0046669 |
18 |
0.018
|
|
|
|
regulation of catalytic activity
|
GO:0050790 |
185 |
0.018
|
|
|
|
single organism intracellular transport
|
GO:1902582 |
207 |
0.018
|
|
|
|
multicellular organismal reproductive behavior
|
GO:0033057 |
110 |
0.018
|
|
|
|
positive regulation of macromolecule metabolic process
|
GO:0010604 |
405 |
0.018
|
|
|
|
purine nucleoside biosynthetic process
|
GO:0042451 |
3 |
0.018
|
|
|
|
phagocytosis
|
GO:0006909 |
215 |
0.018
|
|
|
|
reproductive behavior
|
GO:0019098 |
122 |
0.017
|
|
|
|
regulation of localization
|
GO:0032879 |
275 |
0.017
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
73 |
0.017
|
|
|
|
endocytosis
|
GO:0006897 |
310 |
0.017
|
|
|
|
biological adhesion
|
GO:0022610 |
138 |
0.017
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
127 |
0.016
|
Human |
|
|
negative regulation of cellular metabolic process
|
GO:0031324 |
382 |
0.016
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
112 |
0.016
|
Human |
|
|
cell proliferation
|
GO:0008283 |
299 |
0.016
|
|
|
|
nicotinamide nucleotide metabolic process
|
GO:0046496 |
2 |
0.016
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
112 |
0.016
|
Human |
|
|
single organism catabolic process
|
GO:0044712 |
228 |
0.016
|
Human |
|
|
positive regulation of molecular function
|
GO:0044093 |
136 |
0.016
|
|
|
|
regulation of intracellular signal transduction
|
GO:1902531 |
236 |
0.016
|
|
|
|
salivary gland development
|
GO:0007431 |
162 |
0.016
|
|
|
|
purine nucleoside monophosphate biosynthetic process
|
GO:0009127 |
3 |
0.016
|
|
|
|
negative regulation of nitrogen compound metabolic process
|
GO:0051172 |
265 |
0.016
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
108 |
0.015
|
Human |
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
168 |
0.015
|
Human |
|
|
cellularization
|
GO:0007349 |
90 |
0.015
|
|
|
|
localization of cell
|
GO:0051674 |
257 |
0.015
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
97 |
0.015
|
|
|
|
centrosome organization
|
GO:0051297 |
163 |
0.015
|
|
|
|
exocrine system development
|
GO:0035272 |
162 |
0.014
|
|
|
|
eye morphogenesis
|
GO:0048592 |
260 |
0.014
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
112 |
0.014
|
Human |
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
24 |
0.014
|
|
|
|
programmed cell death
|
GO:0012501 |
257 |
0.014
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
3 |
0.014
|
|
|
|
negative regulation of cellular macromolecule biosynthetic process
|
GO:2000113 |
267 |
0.014
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
25 |
0.014
|
|
|
|
lateral inhibition
|
GO:0046331 |
206 |
0.014
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
47 |
0.014
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
127 |
0.014
|
Human |
|
|
salivary gland morphogenesis
|
GO:0007435 |
145 |
0.014
|
|
|
|
maintenance of location
|
GO:0051235 |
73 |
0.013
|
|
|
|
transcription from rna polymerase ii promoter
|
GO:0006366 |
368 |
0.013
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
260 |
0.013
|
|
|
|
cell adhesion
|
GO:0007155 |
136 |
0.013
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
138 |
0.013
|
|
|
|
multi organism reproductive behavior
|
GO:0044705 |
121 |
0.013
|
|
|
|
single organism biosynthetic process
|
GO:0044711 |
206 |
0.013
|
|
|
|
central nervous system development
|
GO:0007417 |
201 |
0.013
|
Human |
|
|
development of primary sexual characteristics
|
GO:0045137 |
50 |
0.012
|
|
|
|
embryo development ending in birth or egg hatching
|
GO:0009792 |
152 |
0.012
|
|
|
|
ion transport
|
GO:0006811 |
145 |
0.012
|
|
|
|
sperm individualization
|
GO:0007291 |
48 |
0.012
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
3 |
0.012
|
|
|
|
regulation of cell development
|
GO:0060284 |
215 |
0.012
|
|
|
|
locomotory behavior
|
GO:0007626 |
176 |
0.012
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
39 |
0.012
|
|
|
|
single organism behavior
|
GO:0044708 |
391 |
0.012
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
78 |
0.011
|
|
|
|
peptide metabolic process
|
GO:0006518 |
80 |
0.011
|
|
|
|
nad metabolic process
|
GO:0019674 |
1 |
0.011
|
|
|
|
glycosyl compound biosynthetic process
|
GO:1901659 |
3 |
0.011
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
276 |
0.011
|
|
|
|
cell migration
|
GO:0016477 |
238 |
0.011
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
151 |
0.011
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
161 |
0.011
|
Human |
|
|
neurological system process
|
GO:0050877 |
358 |
0.011
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
24 |
0.011
|
|
|
|
gonad development
|
GO:0008406 |
50 |
0.011
|
|
|
|
transmembrane transport
|
GO:0055085 |
139 |
0.010
|
|
|
|
developmental growth
|
GO:0048589 |
280 |
0.010
|
|
|
|
positive regulation of intracellular signal transduction
|
GO:1902533 |
116 |
0.010
|
|
|
|
regulation of programmed cell death
|
GO:0043067 |
152 |
0.010
|
|